Skip to main content

Physiological prehabilitation for patients undergoing cellular therapy in multiple myeloma and lymphoma: a systematic review

In brief

Prehabilitation improved physical function before cell therapy, but evidence remains limited

A review of 12 studies involving 501 people with myeloma or lymphoma found generally favourable physical function and lower-limb performance with exercise before treatment. Most programmes combined aerobic and resistance exercise and lasted 4 to 8 weeks, but strength, quality of life, and fatigue results were mixed; mostly uncontrolled studies leave effectiveness and safety uncertain.

Journal
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer (Q1)
Published
10 November 2026
Study design
Systematic review / meta-analysis of RCTs
Evidence level
Level 1, High (CEBM 1a)
Authors
Janelle Marie Susa Barredo, Chi Ching Lim, Yijun Loy, Melissa Ooi, Yingchun Zeng
PMID
43007455
DOI
10.1007/s00520-026-11427-x

Why clinicians should know about it

  • Picked for Hematology (top studies of the week, 15 November 2026): Prehabilitation review for transplant and CAR-T patients

Abstract

AIMS: To evaluate physiological prehabilitation for adults with multiple myeloma or lymphoma undergoing cellular or immune-based therapies and to describe intervention characteristics and programme duration. BACKGROUND: Fatigue, physical deconditioning, and muscle weakness can compromise treatment readiness and quality of life (QoL). Evidence on exercise begun before these therapies remains limited. METHODS: Six databases were searched from inception to 4 September 2026. Randomised controlled trials (RCTs) and quasi-experimental studies were eligible if exercise began before stem cell transplantation, chimeric antigen receptor T-cell (CAR-T) therapy, or bispecific T-cell engager (BiTE) therapy and assessed physical function plus muscle strength, QoL, or fatigue. Joanna Briggs Institute tools informed methodological appraisal. Findings were synthesised narratively by outcome, alongside exercise characteristics and duration. RESULTS: Twelve studies (501 participants), comprising three pilot RCTs and nine quasi-experimental studies, were included. Ten evaluated transplantation and two CAR-T therapy; none evaluated BiTE therapy. Aerobic plus resistance or strength exercise predominated, and nine programmes reported a central or protocol duration within 4-8 weeks. Physical function and lower-limb performance findings were generally favourable; handgrip strength, QoL, and fatigue findings were mixed. Heterogeneous methods and predominantly uncontrolled designs limited interpretation. CONCLUSIONS: Physiological prehabilitation shows preliminary promise for functional preparation before treatment. Aerobic and resistance exercise and the commonly reported programme durations warrant comparative evaluation. IMPLICATIONS: Adequately powered, therapy-specific RCTs should standardise exercise reporting, assess clinically meaningful outcomes, and evaluate safety and sustained recovery after treatment.

Abstract as published, via PubMed.

View on PubMedFull text at the publisherOpen in the app

For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.